Ana Alastrue-Agudo Selected Research

Therapeutics

5/2021	Human-Induced Neural and Mesenchymal Stem Cell Therapy Combined with a Curcumin Nanoconjugate as a Spinal Cord Injury Treatment.
1/2015	Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury.
10/2012	FM19G11 favors spinal cord injury regeneration and stem cell self-renewal by mitochondrial uncoupling and glucose metabolism induction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Alastrue-Agudo Research Topics

Disease

8	Spinal Cord Injuries (Spinal Cord Injury) 07/2022 - 10/2012
2	Cicatrix (Scar) 05/2021 - 06/2015
2	Paralysis (Palsy) 01/2015 - 10/2012
1	Contusions 07/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2020
1	Gliosis 01/2018
1	Inflammation (Inflammations) 01/2017
1	Hypoxia (Hypoxemia) 10/2012

Drug/Important Bio-Agent (IBA)

2	CurcuminIBA 05/2021 - 01/2017
2	FM19G11IBA 01/2018 - 10/2012
1	Tissue ExtractsIBA 07/2022
1	NanoconjugatesIBA 05/2021
1	TubulinIBA 05/2021
1	GlycosaminoglycansIBA 01/2017
1	PolymersIBA 01/2017
1	connexin 50IBA 11/2015
1	Biocompatible Materials (Biomaterials)IBA 06/2015
1	Purinergic Receptors (Receptors, Purine)IBA 01/2015
1	VimentinIBA 10/2012
1	Glucose (Dextrose)FDA LinkGeneric 10/2012

Therapy/Procedure

3	Therapeutics 05/2021 - 10/2012
3	Cell Transplantation 06/2015 - 10/2012
2	Transplantation 07/2022 - 01/2017
1	Cystectomy 03/2020